|
JPS56158707A
(en)
|
1980-04-08 |
1981-12-07 |
Lion Corp |
Composition for oral use
|
|
JP3496158B2
(ja)
|
1993-01-26 |
2004-02-09 |
東洋カプセル株式会社 |
トラネキサム酸配合ゼラチンカプセル製剤
|
|
US5578568A
(en)
|
1994-04-22 |
1996-11-26 |
Xoma Corporation |
Method of treating conditions associated with intestinal ischemia/reperfusion
|
|
DE19617369A1
(de)
|
1996-04-30 |
1997-11-06 |
Immuno Ag |
Lagerstabile Fibrinogen-Präparate
|
|
JP3940209B2
(ja)
|
1996-11-14 |
2007-07-04 |
株式会社資生堂 |
可溶化化粧料
|
|
US6121232A
(en)
|
1997-01-31 |
2000-09-19 |
Omrix Biopharmaceuticals Sa |
Stabilized mixture comprising fibrinogen
|
|
AU9027298A
(en)
|
1997-08-20 |
1999-03-08 |
Lxr Biotechnology Inc. |
Compositions containing polyethylene glycol and uses thereof
|
|
TWI243687B
(en)
|
1998-04-21 |
2005-11-21 |
Teijin Ltd |
Pharmaceutical composition for application to mucosa
|
|
DE10025001A1
(de)
|
2000-05-22 |
2001-11-29 |
Aventis Behring Gmbh |
Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
|
|
US7276235B2
(en)
|
1998-11-18 |
2007-10-02 |
Zlb Behring Gmbh |
Tissue glue with improved antiadhesive properties
|
|
WO2001037854A1
(en)
|
1999-11-24 |
2001-05-31 |
The Regents Of The University Of California |
Method for treatment and prevention of physiological shock
|
|
US6708822B1
(en)
|
1999-11-30 |
2004-03-23 |
Cutispharma, Inc. |
Compositions and kits for compounding pharmaceuticals
|
|
US20030144212A1
(en)
|
2000-07-06 |
2003-07-31 |
Hoffman Keith B |
Use of serine protease inhibitors to inhibit pathophysiology and neuropathology in a host
|
|
JP4044748B2
(ja)
|
2001-10-17 |
2008-02-06 |
サンスター株式会社 |
口腔用液体組成物
|
|
US20040018984A1
(en)
|
2002-07-17 |
2004-01-29 |
Mizuo Miyazaki |
Methods for preventing adhesion formation using protease inhibitors
|
|
GB0224909D0
(en)
|
2002-10-25 |
2002-12-04 |
Norgine Europe Bv |
Colon cleansing compositions
|
|
ATE544354T1
(de)
|
2002-11-26 |
2012-02-15 |
Univ Chicago |
Vermeidung und behandlung von mikrobenübertragenen epithelerkrankungen
|
|
US20050025825A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Xanodyne Pharmacal, Inc. |
Tranexamic acid formulations with reduced adverse effects
|
|
JP2005068076A
(ja)
|
2003-08-25 |
2005-03-17 |
Tendou Seiyaku Kk |
トラネキサム酸類を含む外用液剤および清拭剤
|
|
US20090215898A1
(en)
|
2004-03-04 |
2009-08-27 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations
|
|
JP2007533755A
(ja)
|
2004-04-20 |
2007-11-22 |
ザ ユニヴァーシティ オヴ シカゴ |
高分子量ｐｅｇ様化合物を含む治療薬送達システム
|
|
US20080194611A1
(en)
|
2005-06-03 |
2008-08-14 |
Alverdy John C |
Modulation of Cell Barrier Dysfunction
|
|
AU2006255274A1
(en)
|
2005-06-03 |
2006-12-14 |
The University Of Chicago |
Modulation of microbial pathogen-host cell interactions
|
|
CA2609985A1
(en)
|
2005-06-03 |
2007-05-10 |
The University Of Chicago |
Modulation of cell barrier dysfunction
|
|
US20090186949A1
(en)
|
2006-02-28 |
2009-07-23 |
The University Of Chicago |
Method for Treating Endothelial and Epithelial Cell Disorders by Administering High Molecular Weight PEG-Like Compounds
|
|
JP5465824B2
(ja)
|
2006-03-24 |
2014-04-09 |
第一三共ヘルスケア株式会社 |
医薬用製剤およびその製造方法
|
|
WO2008103767A1
(en)
|
2007-02-20 |
2008-08-28 |
The Regents Of The University Of California |
Treatment of conditions related to shock
|
|
US8252302B2
(en)
|
2007-06-11 |
2012-08-28 |
Edge Therapeutics, Inc. |
Methods and compositions to treat hemorrhagic conditions of the brain
|
|
JP5093841B2
(ja)
|
2007-07-12 |
2012-12-12 |
株式会社 資生堂 |
不織布含浸化粧料
|
|
WO2009045543A1
(en)
|
2007-10-04 |
2009-04-09 |
The Regents Of The University Of California |
Treatment of conditions related to shock
|
|
WO2010087874A1
(en)
|
2009-01-28 |
2010-08-05 |
Anazyme, Llc |
Compositions and methods for diagnosis of shock
|
|
WO2009132149A2
(en)
|
2008-04-22 |
2009-10-29 |
The Regents Of The University Of California |
Treatment of conditions related to cecal ligation shock
|
|
HRP20140939T1
(hr)
|
2008-05-07 |
2014-11-21 |
Salix Pharmaceuticals, Ltd. |
Davanje preparata za äśišä†enje crijeva i antibiotika za lijeäśenje bolesti crijeva
|
|
US7635707B1
(en)
*
|
2008-11-10 |
2009-12-22 |
Intermune, Inc. |
Pirfenidone treatment for patients with atypical liver function
|
|
ZA201107285B
(en)
|
2009-03-06 |
2012-12-27 |
Delivtx Inc |
Microencapsulated bioactive agents for oral delivery and methods of the thereof
|
|
MX2011009988A
(es)
|
2009-03-23 |
2011-11-18 |
Univ Chicago |
Metodos para la prevencion y el tratamiento de trastornos epiteliales inducidos por radiaciones.
|
|
EP2464413B1
(en)
*
|
2009-08-12 |
2013-10-16 |
Medimetrics Personalized Drug Delivery B.V. |
Medicine reservoir for drug delivery device
|
|
WO2011028234A1
(en)
|
2009-09-04 |
2011-03-10 |
Xenoport, Inc. |
Uses of acyloxyalkyl carbamate prodrugs of tranexamic acid
|
|
EP2624823A4
(en)
|
2010-09-23 |
2016-08-03 |
Inflammagen |
ADMINISTRATION OF SERIN PROTEASE INHIBITORS IN THE STOMACH
|
|
US9295715B2
(en)
|
2010-10-02 |
2016-03-29 |
The Regents Of The University Of California |
Minimizing intestinal dysfunction
|
|
JP6148454B2
(ja)
*
|
2011-11-11 |
2017-06-14 |
ロート製薬株式会社 |
トラネキサム酸を含む外用及び内服用組成物
|
|
ES2375784B1
(es)
|
2011-12-22 |
2013-01-24 |
Laboratorios Kin S.A. |
Gel de ácido tranexámico
|
|
CN103565743B
(zh)
|
2012-07-23 |
2016-06-22 |
上海市徐汇区中心医院 |
氨甲环酸皮肤外用纳米制剂及其制备方法和用途
|
|
WO2014028052A1
(en)
|
2012-08-17 |
2014-02-20 |
The University Of Chicago |
Materials and methods for preventing and treating anastomotic leaks
|
|
CN103054861A
(zh)
*
|
2012-12-29 |
2013-04-24 |
北京阜康仁生物制药科技有限公司 |
一种含氨甲环酸的复方固体制剂
|
|
US20140271923A1
(en)
|
2013-03-14 |
2014-09-18 |
Christopher Brian Reid |
Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
|
|
CA2942358C
(en)
|
2014-03-25 |
2023-03-28 |
Leading BioSciences, Inc. |
Compositions for the treatment of autodigestion
|
|
US20150297619A1
(en)
|
2014-04-17 |
2015-10-22 |
The Regents Of The University Of California |
Methods and compositions for preserving the mucosal barrier
|